JPMorgan Dad Turns Biotech CEO in Disease Quest

Feb. 20 (Bloomberg) -- Ilan Ganot, founder of Solid Ventures, talks about his decision to leave his career to create the biotechnology company after his son, Eytani, was diagnosed with Duchenne muscular dystrophy, a fatal genetic disease. Ganot, a former hedge fund specialist at JPMorgan Chase & Co., now aims to tackle the disease with a strategy he calls condition focus, a sole concentration on DMD. (Source: Bloomberg)
Kleiner Decision on Pao Not Gender Based
07:26 - Brad Stone and Janine Yancey discuss the verdict of the Kleiner-Pao case. They speak with Pimm Fox on "Taking Stock." (Source: Bloomberg)
  • Kleiner Not Guilty of Retaliation
  • Yellen Sees Gradual Rate Increases Starting This Year
  • Kleiner Decision Not Gender Based